Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infection

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Yoon, Miri ^a   Kopp, Sarah J ^a   Taylor, Joann M ^a   Storti, Christopher S ^a   Spear, Patricia G ^a   Muller, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERPESVIRUS ENTRY MEDIATOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NECTIN 1; PROTEIN GD; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; IN VIVO STUDY; MORTALITY; MOUSE; MUCOSAL DISEASE; MUCOSAL INFECTION; NONHUMAN; VAGINA DISEASE; VERO CELL; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MUCOSA INFLAMMATION; MUTATION; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 2; MURINAE; MUS; SIMPLEXVIRUS;

ANIMALS; CHEMOKINES; FEMALE; HERPESVIRUS 2, HUMAN; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MUCOSITIS; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES; VAGINAL DISEASES;

EID: 79551539803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016122     Document Type: Article

References (65)

1. Spear PG (2004) Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 6: 401-410.
2. Spear PG, Eisenberg RJ, Cohen GH (2000) Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275: 1-8.
3. Taylor JM, Lin E, Susmarski N, Yoon M, Zago A, et al. (2007) Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2: 19-28.
4. Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436.
5. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21-30.
6. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, et al. (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6: 90-98.
7. Gonzalez LC, Loyet KM, Calemine-Fenaux J, Chauhan V, Wranik B, et al. (2005) A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci U S A 102: 1116-1121.
8. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, et al. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9: 176-185.
9. Sedý J, Spear P, Ware C (2008) Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8: 861-873.
10. Murphy TL, Murphy KM (2010) Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28: 389-411.
11. Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, et al. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164: 4105-4110.
12. Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, et al. (1998) Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 161: 1786-1794.
13. Sun Y, Brown NK, Ruddy MJ, Miller ML, Lee Y, et al. (2009) B and T lymphocyte attenuator tempers early infection immunity. J Immunol 183: 1946-1951.
14. Manoj S, Jogger C, Myscofski D, Yoon M, Spear P (2004) Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc Natl Acad Sci U S A 101: 12414-12421.
15. Yoon M, Spear P (2004) Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. Proc Nat Acad Sci USA 101: 17252-17257.
16. Yoon M, Zago A, Shukla D, Spear P (2003) Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1. J Virol 77: 9221-9231.
17. Carfí A, Willis S, Whitbeck J, Krummenacher C, Cohen G, et al. (2001) Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell 8: 169-179.
18. Stiles KM, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ, et al. (2010) Herpes simplex virus glycoprotein D interferes with HVEM binding to its ligands through down-regulation and direct competition. J Virol 84: 11646-11660.
19. Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, et al. (2009) Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci U S A 106: 6244-6249.
20. MacLeod IJ, Minson T (2010) Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One 5: e9560.
21. Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC (2005) Antitumor DNA vaccines based on the expression of human papillomavirus-16 E6/ E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes Infect 7: 1541-1550.
22. Lasaro MO, Tatsis N, Hensley SE, Whitbeck JC, Lin SW, et al. (2008) Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nat Med 14: 205-212.
23. Compaan DM, Gonzalez LC, Tom I, Loyet KM, Eaton D, et al. (2005) Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem 280: 39553-39561.
24. Ligas MW, Johnson DC (1988) A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol 62: 1486-1494.
25. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998) Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618-1620.
26. Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, et al. (1998) A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246: 179-189.
27. Shukla D, Liu J, Blaiklock P, Shworak N, Bai X, et al. (1999) A novel role for 3- O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22.
28. Westmoreland D, Rapp F (1976) Host range temperature-sensitive mutants of herpes simplex virus type 2. J Virol 18: 92-102.
29. Andrews BJ, Proteau GA, Beatty LG, Sadowski PD (1985) The FLP recombinase of the 2 micron circle DNA of yeast: interaction with its target sequences. Cell 40: 795-803.
30. Parr M, Kepple L, McDermott M, Drew M, Bozzola J, et al. (1994) A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 70: 369-380.
31. Papaioannou VE, Fox JG (1993) Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci 43: 189-192.
32. Gierynska M, Kumaraguru U, Eo SK, Lee S, Krieg A, et al. (2002) Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. J Virol 76: 6568-6576.
33. Vanderlugt C, Neville K, Nikcevich K, Eagar T, Bluestone J, et al. (2000) Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol 164: 670-678.
34. Wallace M, Keating R, Heath W, Carbone F (1999) The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol 73: 7619-7626.
35. Dolan A, Jamieson F, Cunningham C, Barnett B, McGeoch D (1998) The genome sequence of herpes simplex virus type 2. J Virol 72: 2010-2021.
36. Milligan G, Bernstein D (1995) Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 206: 234-241.
37. Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG (1999) The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol 73: 4493-4497.
38. Wang Y, Subudhi S, Anders R, Lo J, Sun Y, et al. (2005) The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115: 711-717.
39. Murphy KM, Nelson CA, Sedy JR (2006) Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 6: 671-681.
40. Croft M (2005) The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol 26: 292-294.
41. Cai G, Freeman G (2009) The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev 229: 244-258.
42. Milligan GN, Bernstein DI (1995) Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212: 481-489.
43. Nakanishi Y, Lu B, Gerard C, Iwasaki A (2009) CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462: 510-513.
44. Krieg C, Han P, Stone R, Goularte OD, Kaye J (2005) Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol 175: 6420-6427.
45. Schneider K, Potter KG, Ware CF (2004) Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202: 49-66.
46. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T (2010) TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gammastimulated human gingival fibroblasts. Mol Immunol 47: 666-670.
47. Lacotte S, Brun S, Muller S, Dumortier H (2009) CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci 1173: 310-317.
48. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.
49. Bachmann MF, Kopf M, Marsland BJ (2006) Chemokines: more than just road signs. Nat Rev Immunol 6: 159-164.
50. Salazar-Mather TP, Hokeness KL (2006) Cytokine and chemokine networks: pathways to antiviral defense. Curr Top Microbiol Immunol 303: 29-46.
51. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71: 173-183.
52. LeBlanc RA, Pesnicak L, Cabral ES, Godleski M, Straus SE (1999) Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. J Virol 73: 8145-8151.
53. Thapa M, Carr DJ (2008) Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J Virol 82: 10295-10301.
54. Thapa M, Welner RS, Pelayo R, Carr DJ (2008) CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol 180: 1098-1106.
55. Lund JM, Hsing L, Pham TT, Rudensky AY (2008) Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224.
56. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, et al. (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272: 14029-14032.
57. Ohmori Y, Schreiber RD, Hamilton TA (1997) Synergy between interferongamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 272: 14899-14907.
58. Ohmori Y, Hamilton TA (1995) The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol 154: 5235-5244.
59. Barabitskaja O, Foulke JS, Jr., Pati S, Bodor J, Reitz MS, Jr. (2006) Suppression of MIP-1beta transcription in human T cells is regulated by inducible cAMP early repressor (ICER). J Leukoc Biol 79: 378-387.
60. Kovacs SK, Tiwari V, Prandovszky E, Dosa S, Bacsa S, et al. (2009) Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice. Curr Eye Res 34: 896-904.
61. Thapa M, Carr DJ (2009) CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol 83: 9486-9501.
62. Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, et al. (1998) Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol 72: 3595-3601.
63. Zago A, Spear P (2003) Differences in the N termini of herpes simplex virus type 1 and 2 gDs that influence functional interactions with the human entry receptor Nectin-2 and an entry receptor expressed in Chinese hamster ovary cells. J Virol 77: 9695-9699.
64. Warner M, Geraghty R, Martinez W, Montgomery R, Whitbeck J, et al. (1998) A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246: 179-189.
65. Connolly SA, Landsburg DJ, Carfi A, Wiley DC, Cohen GH, et al. (2003) Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J Virol 77: 8127-8140.